Medication info
Candesartan Tablets 16 mg (Candesartan Cilexetil)

Candesartan Tablets 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Pink round tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Approval status
Active

MFDS item code 200909377 · Notified 2009.12.30 · Insurance code 653402270

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients and patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular contractile function
  • reduced left ventricular ejection fraction
View approved original text

This medication is used to treat essential hypertension, effectively lowering blood pressure and improving cardiovascular health. It is also used for patients with heart failure who have reduced left ventricular contractile function, particularly those corresponding to NYHA class II to IV and with a left ventricular ejection fraction of 40% or less. This medication is beneficial in cases where additional treatment with ACE inhibitors is necessary or not tolerated well. It supports heart function and alleviates symptoms, contributing to improving the quality of life for patients. Therefore, it is used for the treatment of essential hypertension and certain heart failure patients.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients and patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.

Precautions

This medication can cause serious harm, especially to the fetus and newborn, during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. This medication should not be taken by individuals with allergies to it or its components, pregnant or nursing women, patients with severe liver impairment or cholestasis, and patients with hereditary angioedema. Elderly patients or those with hyperkalemia, liver impairment, heart valve disease, and impaired kidney function should use this medication cautiously and must frequently check blood pressure and kidney function. During treatment, side effects such as dizziness, back pain, respiratory infections can occur, and patients with heart failure may experience hypotension or worsening kidney function, so caution is necessary. Regular checks of blood pressure, serum potassium, and creatinine levels are important, as excessive lowering of blood pressure or kidney issues may occur. When taken with other antihypertensive drugs, diuretics, or potassium supplements, there could be a heightened risk of side effects due to interactions; therefore, consult a doctor. Caution is required when driving or operating machinery, as dizziness may occur. Women who are pregnant or planning to become pregnant should not take this medication, and it is advisable to avoid use while breastfeeding. In the case of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur, so inform medical personnel immediately and receive appropriate treatment. This medication should be kept out of reach of children and should not be transferred to another container for safety.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • upper respiratory tract infection
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 66 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • weakness
  • fever
  • sensory disturbance
  • indigestion
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyperkalemia
  • hyponatremia
  • hypoglycemia
  • intestinal vasodilation
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • renal impairment
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorder
  • decreased libido
  • memory impairment
  • loss of appetite
  • increased appetite
  • tinnitus
  • dysgeusia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius. This helps preserve the medication's efficacy for a long time.

Appearance and packaging

Appearance

Pink round tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.